EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors

Clinical trial NCT06525298 · RECRUITING

Trial details

NCT number: NCT06525298
Sponsor: Eisbach Bio GmbH
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Homologous Recombination Deficiency HRR Deficiency

Start date: 2024-09-09
Primary completion: 2027-09-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.